The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Sprycel 100 mg tablet 30s. The contract has a potential value of $20,484.54 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that holds a single-award indefinite delivery contract (IDC) with DLA valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Sprycel 100 mg tablets. The $16,006.11 firm-fixed-price delivery order contract has a completion date of June 21, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA to provide a comprehensive...
This federal contract award, valued at $30,962.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Sprycel 50 mg tablets. This contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, Pennsylvania. The contract has an ultimate completion...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $55,285.69 delivery order contract is for the supply of 60-count tablets of Sprycel 50mg, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. AmerisourceBergen, through its Corporate Office division, will provide the requested pharmaceutical product to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sprycel 100 mg tablets. The contract has a ceiling value of $16,276.12 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sprycel 100 mg tablets. The contract has a ceiling value of $27,965.14 and a period of performance through September 6, 2023. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award is for the delivery of pharmaceutical products, primarily the drug Sprycel 100 mg tablet, to support the medical needs of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $13,503.06. It has an ultimate completion date of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Sprycel (dasatinib) 100 mg tablets. The contract, valued at $20,625.93, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 6, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. The contract appears to be part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $34,736.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4,568,143,511 tablets of the prescription medication Sprycel (100 mg) to the government. The contract has a firm fixed price and an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $18,774.53, is for the delivery of the drug Sprycel 100 mg tablets. The award has a completion date of February 28, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...